Showing results (321-330 of 449) with videos related to

Sort By:
Pageof 45
Scientific Reports|April 30, 2020
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaBritta Tjaden, Katharina Baum, Viktoria Marquardt, et al.
International Journal of Cancer|February 13, 2013
MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1AKristina Althoff, Anneleen Beckers, Andrea Odersky, et al.
Acta Neuropathologica Communications|November 21, 2013
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastomaKristian W Pajtler, Christina Weingarten, Theresa Thor, et al.
Plos Computational Biology|November 4, 2021
Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistanceMathurin Dorel, Bertram Klinger, Tommaso Mari, et al.
Transplantation and Cellular Therapy|January 9, 2025
Everolimus with or without Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Children with Acute Kidney Injury: A Single-Center Retrospective AnalysisFelix Zirngibl, Pimrapat Gebert, Bianca Materne, et al.
Zentralblatt Fur Gynakologie|February 3, 2004
[A guideline for guidelines--methodological report and use of the guideline women's information]U-S Albert, K-D Schulz, D Alt, et al.
Cancer Letters|January 7, 2019
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastomaYoujia Han, Sven Lindner, Yi Bei, et al.
Oncotarget|November 27, 2016
Targeting tachykinin receptors in neuroblastomaAnton G Henssen, Andrea Odersky, Annabell Szymansky, et al.
Frontiers in Immunology|January 26, 2023
Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse modelSara Marie Ivasko, Kathleen Anders, Laura Grunewald, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2019
Increased Anaplastic Lymphoma Kinase Activity Induces a Poorly Differentiated Thyroid Carcinoma in MiceHannah Kohler, Soeren Latteyer, Georg Sebastian Hönes, et al.
Pageof 45